TY - GEN
T1 - Real-time monitoring transcranial sub-megahertz ultrasound thrombolysis with phased array scanner
AU - Kubota, Jun
AU - Ogihara, Makoto
AU - Azuma, Takashi
AU - Umemura, Shin Ichiro
AU - Sasaki, Akira
AU - Ando, Kazumi
AU - Shimizu, Jun
AU - Ishibashi, Toshihiro
AU - Tanifuji, Yasumasa
AU - Furuhata, Hiroshi
PY - 2005/12/1
Y1 - 2005/12/1
N2 - Transcranial ultrasonic thrombolytic system has been developed, for acute ischemic stroke (AIS) therapy during hyper acute phase. The system aims to have a higher potential for early recanalization in the thrombo-embolism by accelerating the effect of thrombolytic agent with transcranial ultrasonication. Sub MHz ultrasound has less attenuation by several orders through cranium than that of more than 2MHz, while it has higher risk of intracranial hemorrhage. In order to avoid the risk, the direction of therapeutic ultrasound (T) beam is targeted at an area around the embolic artery, and in order to minimize mechanical and thermal adverse biological effects, T-beam frequency is selected 500 kHz, the acoustic intensity limited less than the maximum regulation level of the diagnostic ultrasound equipment. The transcranial diagnostic (Doppler or color flow imaging) ultrasound (D) beam at 2MHz is used for monitoring the recanalization. The system irradiates both T- and D-beam alternately in the signal control subsystem through a phased array single compound probe. The images by the diagnostic array in the probe are comparable to those by the commercialized sector scanning diagnostic phased array. The probe also has supplied T-beam of the maximum acoustic intensity designated by the regulation for the diagnostic equipment. The margin of safety was confirmed through animal experiments.
AB - Transcranial ultrasonic thrombolytic system has been developed, for acute ischemic stroke (AIS) therapy during hyper acute phase. The system aims to have a higher potential for early recanalization in the thrombo-embolism by accelerating the effect of thrombolytic agent with transcranial ultrasonication. Sub MHz ultrasound has less attenuation by several orders through cranium than that of more than 2MHz, while it has higher risk of intracranial hemorrhage. In order to avoid the risk, the direction of therapeutic ultrasound (T) beam is targeted at an area around the embolic artery, and in order to minimize mechanical and thermal adverse biological effects, T-beam frequency is selected 500 kHz, the acoustic intensity limited less than the maximum regulation level of the diagnostic ultrasound equipment. The transcranial diagnostic (Doppler or color flow imaging) ultrasound (D) beam at 2MHz is used for monitoring the recanalization. The system irradiates both T- and D-beam alternately in the signal control subsystem through a phased array single compound probe. The images by the diagnostic array in the probe are comparable to those by the commercialized sector scanning diagnostic phased array. The probe also has supplied T-beam of the maximum acoustic intensity designated by the regulation for the diagnostic equipment. The margin of safety was confirmed through animal experiments.
KW - Color flow imaging
KW - Doppler
KW - Thrombolysis
KW - Transcranial ultrasound
UR - http://www.scopus.com/inward/record.url?scp=33847094604&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33847094604&partnerID=8YFLogxK
U2 - 10.1109/ULTSYM.2005.1603196
DO - 10.1109/ULTSYM.2005.1603196
M3 - Conference contribution
AN - SCOPUS:33847094604
SN - 0780393821
SN - 9780780393820
T3 - Proceedings - IEEE Ultrasonics Symposium
SP - 1716
EP - 1719
BT - 2005 IEEE Ultrasonics Symposium
T2 - 2005 IEEE Ultrasonics Symposium
Y2 - 18 September 2005 through 21 September 2005
ER -